USE OF THE HIGHLY CONCENTRATED INTRANASAL SPRAY FORMULATION OF DESMOPRESSIN IN MILD HEMOPHILIA-A AND VON-WILLEBRAND DISEASE

被引：0
|
作者：
LUSHER, JM [1 ]
机构：
[1] CHILDRENS HOSP MICHIGAN,DETROIT,MI
来源：
TRANSFUSION | 1995年 / 35卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：445 / 445
页数：1
相关论文
共 50 条
  • [31] FACTOR-VIII-C INCREASES AFTER DESMOPRESSIN IN A SUBGROUP OF PATIENTS WITH AUTOSOMAL RECESSIVE SEVERE VON-WILLEBRAND DISEASE
    CASTAMAN, G
    LATTUADA, A
    MANNUCCI, PM
    RODEGHIERO, F
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (01) : 147 - 151
  • [32] Safety and efficacy of Stimate(R) (desmopressin acetate, 1.5 mg/ml) nasal spray in patients with mild to moderate von Willebrand disease (vWD)
    Becton, D
    Thompson, AR
    Bergman, GE
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : P2842 - P2842
  • [33] Dental extractions in patients with mild hemophilia A and hemophilia B and von Willebrand disease without clotting factor supplementation
    Lewandowski, Bogumil
    Wojnar, Joanna
    Brodowski, Robert
    Mucha, Marta
    Czenczek-Lewandowska, Ewelina
    Brzecka, Dagna
    [J]. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2018, 128 (7-8): : 488 - 490
  • [34] Comparison of intravenous (IV) and intranasal (IN) desmopressin acetate (DDAVP) in patients weighing <=50 kg with mild hemophilia A (HA) or mild to moderate von Willenbrand disease (vWd, type 1)
    Gill, JC
    Ottum, M
    Bergman, GE
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : P2840 - P2840
  • [35] Desmopressin acetate use in von Willebrand's disease: a survey on current practices in Brazil
    Lopes, Maria Sueli da Silva Nameni
    Rezende, Suely Meireles
    [J]. HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2021, 43 (01) : 43 - 49
  • [36] INTRANASAL ADMINISTRATION OF DEAMINO-8-D-ARGININE VASOPRESSIN (DDAVP) FOR TREATMENT OF MILD HEMOPHILIA-A AND VONWILLEBRANDS DISEASE
    STREIT, A
    FURLAN, M
    BECK, EA
    [J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1984, 114 (40) : 1389 - 1391
  • [37] Plasma platelet-activating factor (PAF) levels and desmopressin response in children with hemophilia A and von Willebrand's disease
    Kavakli, K
    Polat, A
    Hüseyinof, A
    Nisli, G
    Aydinok, Y
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, 81 (04) : 665 - 666
  • [38] The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977-2007)
    Federici, A. B.
    [J]. HAEMOPHILIA, 2008, 14 : 5 - 14
  • [39] Desmopressin use in Type 2B von Willebrand disease in North America, a survey of members of the Hemophilia Research Society of North America.
    Kouides, PA
    Brettler, D
    Kasper, C
    Lipton, R
    Manco-Johnson, M
    Pruthi, R
    Sanders, J
    Tarantino, M
    Konkle, B
    [J]. BLOOD, 2002, 100 (11) : 698A - 698A
  • [40] THE USE OF INTERMEDIATE AND HIGH-PURITY FACTOR-VIII PRODUCTS IN THE TREATMENT OF VON-WILLEBRAND DISEASE
    HANNA, WT
    BONA, RD
    ZIMMERMAN, CE
    CARTA, CA
    HEBERT, GZ
    RICKLES, FR
    [J]. THROMBOSIS AND HAEMOSTASIS, 1994, 71 (02) : 173 - 179
12345